From patients’ Ovulona™ units to a physician’s Ovulograph™

Slides:



Advertisements
Similar presentations
Vaclav Kirsner, PhD, Founder CEO bioZhena Corporation (970) Transforming Female Reproductive Health.
Advertisements

Fast, reliable communication Accessible 24/7 and only a click away INSERT LOGO.
1 Vol. 01. p Vol. 01. p Vol. 01. p.20.
1 Vol. 03. p Vol. 03. p Vol. 03. p.21.
1 Vol. 02. p Vol. 02. p Vol. 02. p.19.
1 Vol. 03. p Vol. 03. p Vol. 03. p.16.
1 Vol. 02. p Vol. 02. p Vol. 02. p.30.
1 Vol. 03. p Vol. 03. p Vol. 03. p.35.
1 Vol. 02. p Vol. 02. p Vol. 02. p.10.
1 Vol. 01. p Vol. 01. p Vol. 01. p.14.
BioZhena Corporation 5/13/ Private Placement Offering and/or Strategic Alliance Proposal bioZhena Corporation.
Sleep Management Program Portal Training Guide February 3, 2015.
Vaclav Kirsner, PhD, Founder CEO bioZhena Corporation (970) Transforming Female Reproductive Health.
QUALITY AND ADOPTION TO FAMILY LIFE IN CERVICAL CANCER SURVIVORS AFTER RADIOTHERAPY Dr.Rishan.T.S, Cancer Institute(WIA), Adyar,Chennai.
I. Hospital admissions II. Intervention result in relation to FFN III. Gestational age In relation to FFN IV. In relation to delivery V. Relation of delivery.
Ovulona TM A revolutionary women’s health product & technology platform Personal monitor of cervix uteri © bioZhena Corporation From teen age to menopause.
Vaclav Kirsner, PhD, Founder CEO (970) Transforming Female Reproductive Health Management.
CareConnection’s PowerNote. Accessing PowerNote – Step 1.
The multitude of repeatable measurable features of the cyclic pattern makes it possible to determine the boundaries of the fertile window for every individual.
To Find the Cancer Staging Tool, click on “Go To” and then chose “Cancer Staging”
ПЕЧЕНЬ 9. Закладка печени в период эмбрионального развития.
Stale Curve Query Tool Input Screen 0 – 2 Years 2 – 5 Years 5 + Years Book Type # of Stale % of Total Average Curve Code Portfolio Code Ref. Months.
End the Epidemic Quality Improvement Project 2016.
Vaclav Kirsner, PhD, Founder CEO
Accessing health information in the UK
Folliculogenesis In Vivo™
Ann Intern Med. 2014;160(11): doi: /M Figure Legend:
J.C. Trussell, M.D., Allen R. Kunselman, M.A., Richard S. Legro, M.D. 
Clearly define the problem or challenge
School of Life and Health Sciences, University of Ulster Jordanstown
Vaclav Kirsner, PhD, Founder
WELCOME 12/18/15 Town Hall Meeting.
Introduction With TimeCard users can tag SharePoint events with information that converts them into time sheets. This way they can report.
Vaclav Kirsner, PhD, Founder
BACK SOLUTION:
Embry Women’s Health OB- GYN - Mesa, AZ
R.J. Fehring and W.D. Schlaff, J. Nurse-Midwifery 43 (2), 117, 1998
Using the Answer Booklet
Technology Overview FOLLICULOGENESIS IN VIVO™
Startup version of the Ovulona cervical sensor has FDA clearance
OvulonaTM in bioZhena pro forma financial summary
Lesson 2: Components of Patient Lists
Technology Overview Revolutionary technology –
اهداف کلاس های آمادگي براي زايمان
Usability and utility of the CONSORT calculator for FSH starting doses: a prospective observational study  Jean Luc Pouly, François Olivennes, Nathalie.
HOW TO USE THE ONLINE BRIEFING SYSTEM
IUD Specialist in Mesa - Embry Women’s Health
Ovulona TM A revolutionary women’s health product & technology platform Personal monitor of cervix uteri From teen age to menopause © bioZhena Corporation.
Standard 3.1 Patient Navigation Process
Eric Berger  Annals of Emergency Medicine 
“Defining both the problems and the solutions in healthcare has to be a partnership between professionals and the communities they serve. “ Jeremy Taylor.
Ovulona TM A revolutionary women’s health product & technology platform Personal monitor of cervix uteri From teen age to menopause © bioZhena Corporation.
Friendly Technology Data From Home To Healthcare Providers
Vaclav Kirsner, PhD, Founder
Ovulographic™ Technology
CLICK TO START.
Place Your Name & Title Here
Ovulographic™ Technology
Epilepsy12 Patient Record Summary Dashboard
CLICK TO START.
OvulonaTM detects delayed ovulation
Clinical prediction models
PrnLink.com Training Children's Health System of Texas Getting Started.
OvulonaTM monitors the end-organ effect of all reproductive effectors by measuring bioelectronic admittance of the outer-cervix tissue OvulonaTM basic.
Graphical user-interface of the telerehabilitation programme.
Vaclav Kirsner, PhD, Founder
©Richard Goldman September 16, 2002
Call Now : Click : -
Call Now : Click : -
Call Now : Click : -
Presentation transcript:

From patients’ Ovulona™ units to a physician’s Ovulograph™ Friendly Technology Ovulographic™ Folliculogenesis In Vivo™ (FIV™) screening concurrently cervical health Data From Home To Healthcare Providers Test in Posterior Fornix From patients’ Ovulona™ units to a physician’s Ovulograph™ – when needed Next generation telemetric embodiment for users’ convenience Folliculogenesis data correlated with auxiliary data (e.g. BBT) Importance of the topic: The quality of ovulation is strained in normal women - by Richard S. Legro, Human Reproduction, Vol.28, No.6 pp. 1446–1447, 2013 ‘Improve the methods and criteria used to assess ovulatory dysfunction’ - Click above on Ovulograph to view the shown graphical introduction to our solution